7 June 2021 - Advice on five new medicines for use in conditions including advanced gastric cancer and chronic lymphocytic leukaemia has today been published by the Scottish Medicines Consortium.

Trifluridine/tipiracil (Lonsurf) was accepted for the treatment of advanced gastric cancer following consideration through SMC’s Patient and Clinician Engagement (PACE) process, which is used for medicines for end of life and rare conditions.

Read SMC press release